248 related articles for article (PubMed ID: 36229560)
1. Combining NGN2 programming and dopaminergic patterning for a rapid and efficient generation of hiPSC-derived midbrain neurons.
Sheta R; Teixeira M; Idi W; Pierre M; de Rus Jacquet A; Emond V; Zorca CE; Vanderperre B; Durcan TM; Fon EA; Calon F; Chahine M; Oueslati A
Sci Rep; 2022 Oct; 12(1):17176. PubMed ID: 36229560
[TBL] [Abstract][Full Text] [Related]
2. Efficient generation of A9 midbrain dopaminergic neurons by lentiviral delivery of LMX1A in human embryonic stem cells and induced pluripotent stem cells.
Sánchez-Danés A; Consiglio A; Richaud Y; Rodríguez-Pizà I; Dehay B; Edel M; Bové J; Memo M; Vila M; Raya A; Izpisua Belmonte JC
Hum Gene Ther; 2012 Jan; 23(1):56-69. PubMed ID: 21877920
[TBL] [Abstract][Full Text] [Related]
3. Development of Midbrain Dopaminergic Neurons and the Advantage of Using hiPSCs as a Model System to Study Parkinson's Disease.
Samson JS; Ramesh A; Parvathi VD
Neuroscience; 2024 May; 546():1-19. PubMed ID: 38522661
[TBL] [Abstract][Full Text] [Related]
4. Molecular Features of Parkinson's Disease in Patient-Derived Midbrain Dopaminergic Neurons.
Ren Y; Jiang H; Pu J; Li L; Wu J; Yan Y; Zhao G; Guttuso TJ; Zhang B; Feng J
Mov Disord; 2022 Jan; 37(1):70-79. PubMed ID: 34564901
[TBL] [Abstract][Full Text] [Related]
5. Identifying the optimal developmental age of human pluripotent stem cell-derived midbrain dopaminergic progenitors for transplantation in a rodent model of Parkinson's disease.
de Luzy IR; Pavan C; Moriarty N; Hunt CPJ; Vandenhoven Z; Khanna A; Niclis JC; Gantner CW; Thompson LH; Parish CL
Exp Neurol; 2022 Dec; 358():114219. PubMed ID: 36055392
[TBL] [Abstract][Full Text] [Related]
6. Physiological characterisation of human iPS-derived dopaminergic neurons.
Hartfield EM; Yamasaki-Mann M; Ribeiro Fernandes HJ; Vowles J; James WS; Cowley SA; Wade-Martins R
PLoS One; 2014; 9(2):e87388. PubMed ID: 24586273
[TBL] [Abstract][Full Text] [Related]
7. Optimized protocol for the generation of functional human induced-pluripotent-stem-cell-derived dopaminergic neurons.
Sheta R; Teixeira M; Idi W; Oueslati A
STAR Protoc; 2023 Sep; 4(3):102486. PubMed ID: 37515763
[TBL] [Abstract][Full Text] [Related]
8. Induced dopaminergic neurons: A new promise for Parkinson's disease.
Xu Z; Chu X; Jiang H; Schilling H; Chen S; Feng J
Redox Biol; 2017 Apr; 11():606-612. PubMed ID: 28110217
[TBL] [Abstract][Full Text] [Related]
9. Proneural transcription factor Atoh1 drives highly efficient differentiation of human pluripotent stem cells into dopaminergic neurons.
Sagal J; Zhan X; Xu J; Tilghman J; Karuppagounder SS; Chen L; Dawson VL; Dawson TM; Laterra J; Ying M
Stem Cells Transl Med; 2014 Aug; 3(8):888-98. PubMed ID: 24904172
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional comparison of human induced and primary midbrain dopaminergic neurons.
Xia N; Zhang P; Fang F; Wang Z; Rothstein M; Angulo B; Chiang R; Taylor J; Reijo Pera RA
Sci Rep; 2016 Feb; 6():20270. PubMed ID: 26842779
[TBL] [Abstract][Full Text] [Related]
11. Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology.
Chang YL; Chen SJ; Kao CL; Hung SC; Ding DC; Yu CC; Chen YJ; Ku HH; Lin CP; Lee KH; Chen YC; Wang JJ; Hsu CC; Chen LK; Li HY; Chiou SH
Cell Transplant; 2012; 21(1):313-32. PubMed ID: 21669041
[TBL] [Abstract][Full Text] [Related]
12. Expression and role of nicotinic acetylcholine receptors during midbrain dopaminergic neuron differentiation from human induced pluripotent stem cells.
Kato T; Nishimura K; Hirao M; Shimohama S; Takata K
Neuropsychopharmacol Rep; 2023 Sep; 43(3):440-445. PubMed ID: 37366076
[TBL] [Abstract][Full Text] [Related]
13. Dopamine Neuron Diversity: Recent Advances and Current Challenges in Human Stem Cell Models and Single Cell Sequencing.
Fiorenzano A; Sozzi E; Parmar M; Storm P
Cells; 2021 Jun; 10(6):. PubMed ID: 34206038
[TBL] [Abstract][Full Text] [Related]
14. Synthetic mRNAs Drive Highly Efficient iPS Cell Differentiation to Dopaminergic Neurons.
Xue Y; Zhan X; Sun S; Karuppagounder SS; Xia S; Dawson VL; Dawson TM; Laterra J; Zhang J; Ying M
Stem Cells Transl Med; 2019 Feb; 8(2):112-123. PubMed ID: 30387318
[TBL] [Abstract][Full Text] [Related]
15. Single-Cell Transcriptomics and In Vitro Lineage Tracing Reveals Differential Susceptibility of Human iPSC-Derived Midbrain Dopaminergic Neurons in a Cellular Model of Parkinson's Disease.
Cardo LF; Monzón-Sandoval J; Li Z; Webber C; Li M
Cells; 2023 Dec; 12(24):. PubMed ID: 38132179
[TBL] [Abstract][Full Text] [Related]
16. Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons.
Bono F; Savoia P; Guglielmi A; Gennarelli M; Piovani G; Sigala S; Leo D; Espinoza S; Gainetdinov RR; Devoto P; Spano P; Missale C; Fiorentini C
Mol Neurobiol; 2018 Feb; 55(2):1054-1067. PubMed ID: 28092083
[TBL] [Abstract][Full Text] [Related]
17. From 2D to 3D: Development of Monolayer Dopaminergic Neuronal and Midbrain Organoid Cultures for Parkinson's Disease Modeling and Regenerative Therapy.
Yeap YJ; Teddy TJW; Lee MJ; Goh M; Lim KL
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768843
[TBL] [Abstract][Full Text] [Related]
18. Single-cell transcriptional and functional analysis of dopaminergic neurons in organoid-like cultures derived from human fetal midbrain.
Birtele M; Storm P; Sharma Y; Kajtez J; Wahlestedt JN; Sozzi E; Nilsson F; Stott S; He XL; Mattsson B; Ottosson DR; Barker RA; Fiorenzano A; Parmar M
Development; 2022 Dec; 149(23):. PubMed ID: 36305490
[TBL] [Abstract][Full Text] [Related]
19. Grafts Derived from an α-Synuclein Triplication Patient Mediate Functional Recovery but Develop Disease-Associated Pathology in the 6-OHDA Model of Parkinson's Disease.
Shrigley S; Nilsson F; Mattsson B; Fiorenzano A; Mudannayake J; Bruzelius A; Ottosson DR; Björklund A; Hoban DB; Parmar M
J Parkinsons Dis; 2021; 11(2):515-528. PubMed ID: 33361611
[TBL] [Abstract][Full Text] [Related]
20. Parallel neurodegenerative phenotypes in sporadic Parkinson's disease fibroblasts and midbrain dopamine neurons.
Corenblum MJ; McRobbie-Johnson A; Carruth E; Bernard K; Luo M; Mandarino LJ; Peterson S; Sans-Fuentes MA; Billheimer D; Maley T; Eggers ED; Madhavan L
Prog Neurobiol; 2023 Oct; 229():102501. PubMed ID: 37451330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
